Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Fosmidomycin biosynthesis diverges from related phosphonate natural products

Nature Chemical Biology volume 15, pages 1049–1056 (2019)Cite this article

Subjects

Abstract

Fosmidomycin and related molecules comprise a family of phosphonate natural products with potent antibacterial, antimalarial and herbicidal activities. To understand the biosynthesis of these compounds, we characterized the fosmidomycin producer, Streptomyces lavendulae, using biochemical and genetic approaches. We were unable to elicit production of fosmidomycin, instead observing the unsaturated derivative dehydrofosmidomycin, which we showed potently inhibits 1-deoxy-d-xylulose-5-phosphate reductoisomerase and has bioactivity against a number of bacteria. The genes required for dehydrofosmidomycin biosynthesis were established by heterologous expression experiments. Bioinformatics analyses, characterization of intermediates and in vitro biochemistry show that the biosynthetic pathway involves conversion of a two-carbon phosphonate precursor into the unsaturated three-carbon product via a highly unusual rearrangement reaction, catalyzed by the 2-oxoglutarate dependent dioxygenase DfmD. The required genes and biosynthetic pathway for dehydrofosmidomycin differ substantially from that of the related natural product FR-900098, suggesting that the ability to produce these bioactive molecules arose via convergent evolution.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: The fosmidomycin family of phosphonate natural products.
Fig. 2: S. lavendulae produces dehydrofosmidomycin.
Fig. 3: Characterization of the dfm gene cluster.
Fig. 4: Feeding studies with 2AEP and l-methionine-(methyl-13C).
Fig. 5: Conversion of trimethyl-2AEP to methyldehydrofosmidomycin by DfmD.
Fig. 6: Proposed biosynthetic pathway for dehydrofosmidomycin.

Data availability

The authors declare that all relevant data supporting the findings of this study are available within the paper and its Supplementary Information.

References

  1. Antibiotic Resistance Threats in the United States, Antibiotic/Antimicrobial Resistance (The Centers for Disease Control and Prevention, 2013).

  2. World Malaria Report 2016 (World Health Organization, 2016).

  3. Bain, C., Selfa, T., Dandachi, T. & Velardi, S. ‘Superweeds’ or ‘survivors’? Framing the problem of glyphosate resistant weeds and genetically engineered crops. J. Rural Stud. 51, 211–221 (2017).

    Google Scholar 

  4. Newman, D. J. & Cragg, G. M. Natural products as sources of new drugs from 1981 to 2014. J. Nat. Prod. 79, 629–661 (2016).

    CAS  PubMed  Google Scholar 

  5. Doroghazi, J. R. et al. A roadmap for natural product discovery based on large-scale genomics and metabolomics. Nat. Chem. Biol. 10, 963–968 (2014).

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Ju, K.-S. et al. Discovery of phosphonic acid natural products by mining the genomes of 10,000 actinomycetes. Proc. Natl Acad. Sci. USA 112, 12175–12180 (2015).

    CAS  PubMed  Google Scholar 

  7. Iguchi, E., Okuhara, M., Kohsaka, M., Aoki, H. & Imanaka, H. Studies on new phosphonic acid antibiotics. II. Taxonomic studies on producing organisms of the phosphonic acid and related compounds. J. Antibiot. 33, 19–23 (1980).

    CAS  PubMed  Google Scholar 

  8. Okuhara, M. et al. Studies on new phosphonic acid antibiotics. III. Isolation and characterization of FR-31564, FR-32863 and FR-33289. J. Antibiot. 33, 24–28 (1980).

    CAS  PubMed  Google Scholar 

  9. Kuroda, Y. et al. Studies on new phosphonic acid antibiotics. IV. Structure determination of FR-33289, FR-31564 and FR-32863. J. Antibiot. 33, 29–35 (1980).

    CAS  PubMed  Google Scholar 

  10. Okuhara, M. et al. Studies on new phosphonic acid antibiotics. I. FR-900098, isolation and characterization. J. Antibiot. 33, 13–17 (1980).

    CAS  PubMed  Google Scholar 

  11. Davey, M. S. et al. A promising target for treatment of multidrug-resistant bacterial infections. Antimicrob. Agents Chemother. 55, 3635–3636 (2011).

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Jomaa, H. et al. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science 285, 1573–1576 (1999).

    CAS  Google Scholar 

  13. Fernandes, J. F. et al. Fosmidomycin as an antimalarial drug: a meta-analysis of clinical trials. Future Microbiol. 10, 1375–1390 (2015).

    CAS  PubMed  Google Scholar 

  14. Kuzuyama, T., Shimizu, T., Takahashi, S. & Seto, H. Fosmidomycin, a specific inhibitor of 1-deoxy-d-xylulose 5-phosphate reductoisomerase in the nonmevalonate pathway for terpenoid biosynthesis. Tetrahedron Lett. 39, 7913–7916 (1998).

    CAS  Google Scholar 

  15. Coppens, I. Targeting lipid biosynthesis and salvage in apicomplexan parasites for improved chemotherapies. Nat. Rev. Microbiol. 11, 823–835 (2013).

    CAS  PubMed  Google Scholar 

  16. Hartmann, M. et al. The effect of MEP pathway and other inhibitors on the intracellular localization of a plasma membrane-targeted, isoprenylable GFP reporter protein in tobacco BY-2 cells. F1000Res. 2, 170 (2013).

    PubMed  PubMed Central  Google Scholar 

  17. Hunter, W. N. The non-mevalonate pathway of isoprenoid precursor biosynthesis. J. Biol. Chem. 282, 21573–21577 (2007).

    CAS  Google Scholar 

  18. Lichtenthaler, H. K., Zeidler, J., Schwender, J. & Müller, C. The non-mevalonate isoprenoid biosynthesis of plants as a test system for new herbicides and drugs against pathogenic bacteria and the malaria parasite. Z. Naturforsch. C 55, 305–313 (2000).

    CAS  PubMed  Google Scholar 

  19. Eliot, A. C. et al. Cloning, expression, and biochemical characterization of Streptomyces rubellomurinus genes required for biosynthesis of antimalarial compound FR900098. Chem. Biol. 15, 765–770 (2008).

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Johannes, T. W. et al. Deciphering the late biosynthetic steps of antimalarial compound FR-900098. Chem. Biol. 17, 57–64 (2010).

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Peck, S. C. & van der Donk, W. A. Phosphonate biosynthesis and catabolism: a treasure trove of unusual enzymology. Curr. Opin. Chem. Biol. 17, 580–588 (2013).

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Metcalf, W. W. & van der Donk, W. A. Biosynthesis of phosphonic and phosphinic acid natural products. Annu. Rev. Biochem. 78, 65–94 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Horsman, G. P. & Zechel, D. L. Phosphonate biochemistry. Chem. Rev. 117, 5704–5783 (2017).

    CAS  PubMed  Google Scholar 

  24. Sindt, M., Stephan, B., Schneider, M. & Mieloszynski, J. L. Chemical shift prediction of 31 P-NMR shifts for dialkyl or diaryl phosphonates. Phosphorus Sulfur Silicon Relat. Elem. 174, 163–175 (2001).

    CAS  Google Scholar 

  25. Hemmi, K., Takeno, H., Hashimoto, M. & Kamiya, T. Studies on phosphonic acid antibiotics. IV. Synthesis and antibacterial activity of analogs of 3-(N-acetyl-N-hydroxyamino)-propylphosphonic acid (FR-900098). Chem. Pharm. Bull. 30, 111–118 (1982).

    CAS  PubMed  Google Scholar 

  26. Wang, X. et al. MEPicides: α,β-unsaturated fosmidomycin analogues as DXR Inhibitors against malaria. J. Med. Chem. 61, 8847–8858 (2018).

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Waditee, R. et al. Isolation and functional characterization of N-methyltransferases that catalyze betaine synthesis from glycine in a halotolerant photosynthetic organism Aphanothece halophytica. J Biol. Chem. 278, 4932–4942 (2003).

    CAS  PubMed  Google Scholar 

  28. Martinez-Morales, F., Schobert, M., López-Lara, I. M. & Geiger, O. Pathways for phosphatidylcholine biosynthesis in bacteria. Microbiology 149, 3461–3471 (2003).

    CAS  PubMed  Google Scholar 

  29. Geiger, O., López-Lara, I. M. & Sohlenkamp, C. Phosphatidylcholine biosynthesis and function in bacteria. Biochim. Biophys. Acta – Mol. Cell Biol. Lipids 1831, 503–513 (2013).

    CAS  Google Scholar 

  30. Blodgett, J. A. V. et al. Unusual transformations in the biosynthesis of the antibiotic phosphinothricin tripeptide. Nat. Chem. Biol. 3, 480–485 (2007).

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Loenarz, C. & Schofield, C. J. Physiological and biochemical aspects of hydroxylations and demethylations catalyzed by human 2-oxoglutarate oxygenases. Trends Biochem. Sci. 36, 7–18 (2011).

    CAS  PubMed  Google Scholar 

  32. Herr, C. Q. & Hausinger, R. P. Amazing diversity in biochemical roles of Fe(II)/2-oxoglutarate oxygenases. Trends Biochem. Sci. 43, 517–532 (2018).

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Islam, M. S., Leissing, T. M., Chowdhury, R., Hopkinson, R. J. & Schofield, C. J. 2-Oxoglutarate-dependent oxygenases. Annu. Rev. Biochem. 87, 585–620 (2018).

    CAS  PubMed  Google Scholar 

  34. Dong, C., Zhang, H., Xu, C., Arrowsmith, C. H. & Min, J. Structure and function of dioxygenases in histone demethylation and DNA/RNA demethylation. IUCr. J. 1, 540–549 (2014).

    CAS  Google Scholar 

  35. Valegård, K. et al. Structure of a cephalosporin synthase. Nature 394, 805–809 (1998).

    PubMed  Google Scholar 

  36. Salowe, S. P., Marsh, E. N. & Townsend, C. A. Purification and characterization of clavaminate synthase from Streptomyces clavuligerus: an unusual oxidative enzyme in natural product biosynthesis. Biochemistry 29, 6499–6508 (1990).

    CAS  PubMed  Google Scholar 

  37. Zhang, Z. et al. Crystal structure of a clavaminate synthase-Fe(II)-2-oxoglutarate-substrate-NO complex: evidence for metal centered rearrangements. FEBS Lett. 517, 7–12 (2002).

    CAS  PubMed  Google Scholar 

  38. Rydzik, A. M. et al. Comparison of the substrate selectivity and biochemical properties of human and bacterial γ-butyrobetaine hydroxylase. Org. Biomol. Chem. 12, 6354–6358 (2014).

    CAS  PubMed  Google Scholar 

  39. Henry, L., Leung, I. K. H., Claridge, T. D. W. & Schofield, C. J. γ-Butyrobetaine hydroxylase catalyses a Stevens type rearrangement. Bioorg. Med. Chem. Lett. 22, 4975–4978 (2012).

    CAS  PubMed  Google Scholar 

  40. Leung, I. K. H. et al. Structural and mechanistic studies on γ-utyrobetaine hydroxylase. Chem. Biol. 17, 1316–1324 (2010).

    CAS  PubMed  Google Scholar 

  41. Kobayashi, S., Kuzuyama, T. & Seto, H. Characterization of the fomA and fomB gene products from Streptomyces wedmorensis, which confer fosfomycin resistance on Escherichia coli. Antimicrob. Agents Chemother. 44, 647–650 (2000).

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Kim, S. Y. et al. Different biosynthetic pathways to fosfomycin in Pseudomonas syringae and Streptomyces peciess. Antimicrob. Agents Chemother. 56, 4175–4183 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Basic local alignment search tool. J. Mol. Biol. 215, 403–410 (1990).

    CAS  Google Scholar 

  44. Datsenko, K. A. & Wanner, B. L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl Acad. Sci. USA 97, 6640–6645 (2000).

    CAS  PubMed  Google Scholar 

  45. Patel, J. B. et al. Methods for Dilution Antimicrobial Susceptibilities Tests for Bacteria tThat Grow Aerobically; Approved Standard 10th edn. (Clinical and Laboratory Standards Institute, 2015).

  46. Blodgett, J. A. V., Zhang, J. K. & Metcalf, W. W. Molecular cloning, sequence analysis, and heterologous expression of the phosphinothricin tripeptide biosynthetic gene cluster from Streptomyces viridochromogenes DSM 40736. Antimicrob. Agents Chemother. 49, 230–240 (2005).

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Yu, X., Price, N. P. J., Evans, B. S. & Metcalf, W. W. Purification and characterization of phosphonoglycans from Glycomyces sp. strain NRRL B-16210 and Stackebrandtia nassauensis NRRL B-16338. J. Bacteriol. 196, 1768–1779 (2014).

    PubMed  PubMed Central  Google Scholar 

  48. Wang, S., Cui, X. & Fang, G. Rapid determination of formaldehyde and sulfur dioxide in food products and Chinese herbals. Food Chem. 103, 1487–1493 (2007).

    CAS  Google Scholar 

Download references

Acknowledgements

We thank M. Goettge and K. Wang for helpful discussions, X. Guan for his assistance with NMR experiments, Z. Li for his assistance with HRMS experiments, the UIUC Core Sequencing Facility for sequencing and P. Hergenrother (Chemistry Department, UIUC) for providing strains. This work was funded by the National Institutes of Health (grant nos. P01 GM077596 and R01GM127659 to W.W.M. and F32GM120999 to E.I.P.). NMR spectra were recorded on an instrument purchased with support from NIH grant no. S10 RR028833.

Author information

Author notes

  1. Elizabeth I. Parkinson

    Present address: Department of Chemistry, Purdue University, West Lafayette, IN, USA

  2. Kou-San Ju

    Present address: Department of Microbiology and the Division of Medicinal Chemistry and Pharmacognosy, The Ohio State University, Columbus, OH, USA

Authors and Affiliations

  1. Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, USA

    Elizabeth I. Parkinson, Annette Erb, Kou-San Ju & William W. Metcalf

  2. Department of Microbiology, University of Illinois at Urbana-Champaign, Urbana, IL, USA

    Andrew C. Eliot & William W. Metcalf

Authors
  1. Elizabeth I. Parkinson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Annette Erb
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrew C. Eliot
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kou-San Ju
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. William W. Metcalf
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

E.I.P., A.E. and K.-S.J. optimized growth conditions. E.I.P. performed the chemical syntheses, bioactivity analyses and in vitro characterization of enzymes. A.C.E. made the heterologous expression vector. E.I.P. performed the heterologous expression studies and the deletion mutant studies. E.I.P. and W.W.M. analyzed the data and wrote the manuscript, with assistance of A.E., A.C.E. and K.-S.J.

Corresponding author

Correspondence to William W. Metcalf.

Ethics declarations

Competing interests

W.W.M. has financial interest in Microbial Pharmaceuticals.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary Information

Supplementary Tables 1–5, Supplementary Figures 1–14 and Supplementary Note 1

Reporting Summary

Supplementary Note 2

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Parkinson, E.I., Erb, A., Eliot, A.C. et al. Fosmidomycin biosynthesis diverges from related phosphonate natural products. Nat Chem Biol 15, 1049–1056 (2019). https://doi.org/10.1038/s41589-019-0343-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41589-019-0343-1

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing